Arab Finance: Arab Pharmaceuticals Company registered a net profit after tax of EGP 28.222 million in the first quarter (Q1) of fiscal year (FY) 2026/2027, as per the unaudited financial results.
The profits registered in the three-month period that ended on September 30, 2026, dropped by 54% year-on-year (YoY) from EGP 62.016 million.
Basic earnings per share (EPS) fell to EGP 2.09 from EGP 4.53, while sales increased by 7% to EGP 328.673 million from EGP 306.024 million.
During FY 2025/26, the company’s net profits climbed by 16% YoY to EGP 263.594 million from EGP 227.858 million.